|
1
|
Somlyo AP and Somlyo AV: Signal
transduction and regulation in smooth muscle. Nature. 372:231–236.
1994. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kamm KE and Stull JT: The function of
myosin and myosin light chain kinase phosphorylation in smooth
muscle. Annu Rev Pharmacol Toxicol. 25:593–620. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wickman G, Lan C and Vollrath B:
Functional roles of the rho/rho kinase pathway and protein kinase C
in the relevance regulation of cerebrovascular constriction
mediated by hemoglobin: relevance to subarachnoid hemorrhage and
vasospasm. Circ Res. 92:809–816. 2003. View Article : Google Scholar
|
|
4
|
Ito M, Nakano T, Erdodi F and Hartshorne
DJ: Myosin phosphatase: structure, regulation and function. Mol
Cell Biochem. 259:197–209. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Somlyo AP and Somlyo AV: Signal
transduction by G-proteins, rho-kinase and protein phosphatase to
smooth muscle and non-muscle myosin II. J Physiol. 522:177–185.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hedges JC, Oxhorn BC, Carty M, Adam LP,
Yamboliev IA and Gerthoffer WT: Phosphorylation of caldesmon by ERK
MAP kinases in smooth muscle. Am J Physiol Cell Physiol.
278:718–726. 2000.PubMed/NCBI
|
|
7
|
Yamboliev IA, Hedges JC, Mutnick JL, Adam
LP and Gerthoffer WT: Evidence for modulation of smooth muscle
force by the p38 MAP kinase/HSP27 pathway. Am J Physiol Heart Circ
Physiol. 278:1899–1907. 2000.PubMed/NCBI
|
|
8
|
Gorenne I, Su X and Moreland RS: Caldesmon
phosphorylation is catalyzed by two kinases in permeabilized and
intact vascular smooth muscle. J Cell Physiol. 198:461–469. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou J, Li M, Liu L, Sheng CQ, Li Z, Wang
Y, Zhou JR, Jiang ZP, Chen YZ and Jiang CL: A novel strategy for
development of glucocorticoids through non-genomic mechanism. Cell
Mol Life Sci. 9:1–10. 2010.
|
|
10
|
Zhou J, Liu DF, Liu C, Kang ZM, Shen XH,
Chen YZ, Xu T and Jiang C: Glucocorticoids inhibit degranulation of
mast cells in allergic asthma via nongenomic mechanism. Allergy.
63:1177–1185. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun HW, Miao CY, Liu L, Zhou J, Su DF,
Wang YX and Jiang CL: Rapid inhibitory effect of glucocorticoids on
airway smooth muscle contractions in guinea pigs. Steriods.
71:154–159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu L, Wang YX, Zhou J, Long F, Sun HW,
Liu Y, Chen YZ and Jiang CL: Rapid nongenomic inhibitory effects of
glucocorticoids on human neutrophil degranulation. Inflam Res.
54:37–41. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang S and Zhang L: Glucocorticoids and
vascular reactivity. Curr Vasc Pharmacol. 2:1–12. 2004. View Article : Google Scholar
|
|
14
|
Mansart A, Bollaert PE, Giummelly P,
Capdeville-Atkinson C and Atkinson J: Effects of dexamethasone and
L-canavanine on the intracellular calcium-contraction relation of
the rat tail artery during septic shock. Am J Physiol Heart Circ
Physiol. 291:H1177–H1182. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takakura K, Xiaohong W, Takeuchi K, Yasuda
Y and Fukuda S: Deactivation of norepinephrine by peroxynitrite as
a new pathogenesis in the hypotension of septic shock.
Anesthesiology. 98:928–934. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jeon SB, Jin F, Kim JI, Kim SH, Suk K,
Chae SC, Jun JE, Park WH and Kim IK: A role for rho kinase in
vascular contraction evoked by sodium fluoride. Biochem Biophys Res
Commun. 343:27–33. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Somlyo AP and Somlyo AV: Ca2+
sensitivity of smooth muscle and nonmuscle myosin: modulated by G
proteins, kinases andmyosin phosphatase. Physiol Rev. 83:1325–1358.
2003.
|
|
18
|
Mansart A, Bollaert PE, Seguin C, Levy B,
Longrois D and Mallie JP: Hemodynamic effects of early versus late
glucocorticoid administration in experimental septic shock. Shock.
19:38–44. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zaloga GP and Marik P:
Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin.
17:25–41. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Annane D, Bellissant E, Sebille V, Lesieur
O, Mathieu B, Raphael JC and Gajdos P: Impaired pressor sensitivity
to noradrenaline in septic shock patients with and without impaired
adrenal function reserve. Br J Clin Pharmacol. 46:589–597. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hilgers RH and Webb RC: Molecular aspects
of arterial smooth muscle contraction: focus on Rho. Exp Biol Med.
230:829–835. 2005.PubMed/NCBI
|
|
22
|
Ihara E, Moffat L, Ostrander J, Walsh MP
and Macdonald JA: Characterization of protein kinase pathways
responsible for Ca2+ sensitization in rat ileal
longitudinal smooth muscle. Am J Physiol Gastrointest Liver
Physiol. 293:699–710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Loirand G, Guerin P and Pacaud P: Rho
kinases in cardiovascular physiology and pathophysiology. Circ Res.
98:322–334. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Noma K, Oyama N and Liao JK: Physiological
role of ROCKs in the cardiovascular system. Am J Physiol Cell
Physiol. 290:C661–C668. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shimokawa H and Takeshita A: Rho-kinase is
an important therapeutic target in cardiovascular medicine.
Arterioscler Thromb Vasc Biol. 25:1767–1775. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hirokazu T, Hiroki C, Tadashi I, Jun K,
Haruhiko M, Yoshisato T, Miyako T, Kazuhiko Y, Masaki N and Hisashi
S: Diverse activation states of RhoA in human lung cancer cells:
contribution of G protein coupled receptors. Int J Oncol.
30:709–715. 2007.PubMed/NCBI
|
|
27
|
Bellizzi A, Mangia A, Chiriatti A, Petroni
S, Quaranta M, Schittulli F, Malfettone A, Cardone RA, Paradiso A
and Reshkin SJ: RhoA protein expression in primary breast cancers
and matched lymphocytes is associated with progression of the
disease. Int J Mol Med. 22:25–31. 2008.PubMed/NCBI
|
|
28
|
Baek I, Jeon SB, Kim J, Seok YM, Song MJ,
Chae SC, Jun JE, Park WH and Kim IK: A role for Rho-kinase in
Ca2+ independent contractions induced by
phorbol-12,13-dibutyrate. Clin Exp Pharmacol Physiol. 36:256–261.
2009.
|
|
29
|
Li T, Liu L, Liu J, Ming J, Xu J, Yang G
and Zhang Y: Mechnisms of Rho kinase regulation of vascular
reactivity following hemorrhagic shock in rats. Shock. 29:65–70.
2008.PubMed/NCBI
|
|
30
|
Chiba Y, Goto K, Hirahara M, Sakai H and
Misawa M: Glucocorticoids ameliorate antigen-induced bronchial
smooth muscle hyperresponsiveness by inhibiting upregulation of
RhoA in rats. J Pharmacol Sci. 106:615–625. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Berridge MJ: Smooth muscle cell calcium
activation mechanisms. J Physiol. 586:5047–5061. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tseng S, Kim R, Kim T, Morgan KG and Hai
CM: F-actin disruption attenuates agonist-induced
[Ca2+], myosin phosphorylation and force in smooth
muscle. Am J Physiol. 41:1960–1967. 1997.PubMed/NCBI
|
|
33
|
Tang DC, Xiang JZ and Lu WT: Calponin: a
new regulatory protein for smooth muscle contraction. Prog Biochem
Biophys. 23:325–329. 1996.
|
|
34
|
Matrougui K, Tanko LB, Loufrani L, Gorny
D, Levy BI, Tedgui A and Henrion D: Involvement of rho-kinase and
the actin filament network in angiotensin II-induced contraction
and extracellular signal-regulated kinase activity in intact rat
mesenteric resistance arteries. Arterioscler Thromb Vasc Biol.
21:1288–1293. 2001. View Article : Google Scholar
|
|
35
|
Roberts RE: The role of Rho kinase and
extracellular regulated kinase-mitogen-activated protein kinase in
α2-adrenoceptor-mediaed vasoconstriction in the porcine
palmar lateral vein. J Pharmacol Exp Ther. 311:742–747. 2004.
|
